About
NanoGhost is a pre-clinical synthetic biology company developing a targeted drug delivery platform (Nano-Ghosts) derived from mesenchymal stem cell membranes that preserves MSC tropism to tumors to selectively penetrate and deliver therapeutics to cancer and sites of inflammation.
Explore NanoGhost's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.